Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
出版年份 2019 全文链接
标题
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
作者
关键词
-
出版物
NATURE MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-03-05
DOI
10.1038/s41591-019-0374-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
- (2018) Tae Kon Kim et al. TRENDS IN IMMUNOLOGY
- Cell-based glycan arrays for probing glycan–glycan binding protein interactions
- (2018) Jennie Grace Briard et al. Nature Communications
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Identification of Siglec Ligands Using a Proximity Labeling Method
- (2017) Lanyi Chang et al. JOURNAL OF PROTEOME RESEARCH
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline
- (2016) Hao Chen et al. PLoS Computational Biology
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy
- (2016) Yu Zhang et al. JAMA Oncology
- Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice
- (2016) Clément Ricard et al. Scientific Reports
- Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis
- (2015) Tomohiro Shimizu et al. BONE
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
- (2015) Jacob H. Levine et al. CELL
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Antagonists of PD-1 and PD-L1 in Cancer Treatment
- (2015) Evan J. Lipson et al. SEMINARS IN ONCOLOGY
- Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) J. R. Brown et al. CLINICAL CANCER RESEARCH
- In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
- (2014) K. A. Schalper et al. CLINICAL CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption
- (2014) Matthew Stuible et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity
- (2014) Dallas B. Flies et al. JOURNAL OF CLINICAL INVESTIGATION
- An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells
- (2014) Janet Kerstin Peper et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Mitigating the toxic effects of anticancer immunotherapy
- (2014) Tara C. Gangadhar et al. Nature Reviews Clinical Oncology
- Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer--Response
- (2013) M. Sznol et al. CLINICAL CANCER RESEARCH
- Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12
- (2013) Yusuke Kameda et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice
- (2012) Yoshiharu Hiruma et al. BONE
- The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathway
- (2012) R. Takamiya et al. GLYCOBIOLOGY
- Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)
- (2012) Norihiro Ishida-Kitagawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen
- (2012) Jennifer M. Bordeaux et al. PLoS One
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation
- (2011) Yoshiharu Hiruma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- B7-H2 Is a Costimulatory Ligand for CD28 in Human
- (2011) Sheng Yao et al. IMMUNITY
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started